Denise Zamore - 01 Apr 2025 Form 4 Insider Report for agilon health, inc. (AGL)

Role: Chief Legal Officer
Signature: /s/ Mimi Yang, as Attorney-in-Fact
Issuer symbol: AGL
Transactions as of: 01 Apr 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Apr 2025, 19:39:33 UTC
Previous filing: 24 Mar 2025
Next filing: 16 Apr 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGL	Common Stock	Award	$0	+245,099	+120%	$0.000000	450,047	01 Apr 2025	Direct	F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGL	Options (Right to buy)	Award	$0	+384,616		$0.000000	384,616	01 Apr 2025	Common Stock	384,616	$4.08	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.
F2	Includes Performance Stock Units which may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
F3	Includes restricted stock units.
F4	Options that vest in three equal installments on each anniversary of April 1, 2025, subject to continued employment.